Not Yet RecruitingPhase 2Phase 3ACTRN12606000024549
Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis
Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis of the knees and/or hips
Sponsor
Healtheries of New Zealand Ltd
Enrollment
100 participants
Start Date
Jan 30, 2006
Study Type
Interventional
Conditions
Eligibility
Sex: Both males and femalesMin Age: 18 YearssMax Age: 75 Yearss
Plain Language Summary
Simplified for easier understanding
This clinical trial is studying Randomised placebo controlled trial on the safety and efficacy of Biolane in osteoarthritis. You may be eligible if you are people aged 18 to 75 with total womac score of >30 at baseline-x-ray and clinical evidence of osteoarthritis of the knees and/or hips. Participation typically involves medical assessments, possible treatment with the study intervention, and follow-up visits to track your health.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Biolane for a period of 18 weeks
Biolane for a period of 18 weeks
Locations(1)
View Full Details on ANZCTR
For the most up-to-date information, visit the official listing.
ACTRN12606000024549